 |
|
|
| |
| |
| Hulbert
Ranking |
.gif) |
|
Peter Brimelow: 'A detailed review of Medical Technology Stock Letter (like the one we did a couple of years ago) reveals real strengths, as borne out by the fact that it's repeatedly been able to pull itself back into Hulbert's top-performing group in the past, through the incredible feat of registering year-on-year triple-digit gains.'
For full article, click here.
By Peter Brimelow, MarketWatch
May 23, 2005
* * * * * * * * *
Peter Brimelow:
'The McCamants' Medical Technology Stock Letter was my Investment Letter of the Year in 2003, the top performer by Hulbert Financial Digest count, up some 120 percent ... Looked at on an HFD chart, its repeated bursts of success soar repeatedly above the market's steady gains like a range of Matterhorns above a range of foothills.'
For full article, click here.
By Peter Brimelow, Investor's Business Daily
June 4, 2004
|
|
|
|
| Portfolio
Performance |
|
May 2, 2008 through May 8, 2008:
Model Portfolio - Down 4.1%
Trader's Portfolio - Down 7.0%
S&P500 - Down 0.8%
Nasdaq - Down 1.2%
|
|
| |
NASDAQ |
S&P500 |
Model |
Traders |
| Last week |
-1.2 |
-0.8 |
-4.1 |
-7.0 |
| 2008 year to date |
-7.6 |
-4.8 |
-6.0 |
-5.9 |
| Calendar Year 2007 |
9.8 |
3.5 |
-14.9 |
-27.6 |
| Calendar Year 2006 |
9.5 |
13.6 |
0.4 |
-0.7 |
| Calendar Year 2005 |
1.4 |
3.0 |
-3.0 |
25.5 |
|
|
|
|
|
What Do People Say About MTSL?
'Please accept my thanks for providing the help that even those of us whose careers are in biotechnology require to navigate towards investment success. I look forward to future issues and to a long relationship with The Medical Technology Stock Letter.'
Arnold D. Gale, M.D., FAAP
| |
'After reading hundreds of financial newsletters every week for over 20 years, I can tell you that the Medical Technology Stock Letter is one of just a small handful of newsletters that I consider a must-read for all serious growth investors. In terms of knowledge, expertise and advice on biotechnology stocks, John McCamant is quite simply the very best in the business.'
Steven Halpern
Publisher and Editor of thestockadvisors
|
|
